Delay in onset of metabolic alkalosis during regional citrate anti-coagulation in continous renal replacement therapy with calcium-free replacement solution

Regional citrate anti-coagulation for continuous renal replacement therapy chelates calcium to produce the anti- coagulation effect. We hypothesise that a calcium-free replacement solution will require less citrate and produce fewer metabolic side effects. Fifty patients, in a Medical Inte...

Full description

Bibliographic Details
Main Authors: See Kay, Lee Margaret, Mukhopadhyay Amartya
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2009-01-01
Series:Annals of Cardiac Anaesthesia
Subjects:
Online Access:http://www.annals.in/article.asp?issn=0971-9784;year=2009;volume=12;issue=2;spage=122;epage=126;aulast=See
_version_ 1818561925391319040
author See Kay
Lee Margaret
Mukhopadhyay Amartya
author_facet See Kay
Lee Margaret
Mukhopadhyay Amartya
author_sort See Kay
collection DOAJ
description Regional citrate anti-coagulation for continuous renal replacement therapy chelates calcium to produce the anti-&#8197;coagulation effect. We hypothesise that a calcium-free replacement solution will require less citrate and produce fewer metabolic side effects. Fifty patients, in a Medical Intensive Care Unit of a tertiary teaching hospital (25 in each group), received continuous venovenous hemofiltration using either calcium-containing or calcium-free replacement solutions. Both groups had no significant differences in filter life, metabolic alkalosis, hypernatremia, hypocalcemia, and hypercalcemia. However, patients using calcium-containing solution developed metabolic alkalosis earlier, compared to patients using calcium-free solution (mean 24.6 hours,CI 0.8-48.4 vs. 37.2 hours, CI 9.4-65, <i> P </i> = 0.020). When calcium-containing replacement solution was used, more citrate was required (mean 280ml/h, CI 227.2-332.8 vs. 265ml/h, CI 203.4-326.6, <i> P </i> = 0.069), but less calcium was infused (mean 21.2 ml/h, CI 1.2-21.2 vs 51.6ml/h, CI 26.8-76.4, <i> P </i>&#8804; 0.0001).
first_indexed 2024-12-14T00:57:04Z
format Article
id doaj.art-145f0ab878354b13a48d19c1f10a1e4b
institution Directory Open Access Journal
issn 0971-9784
language English
last_indexed 2024-12-14T00:57:04Z
publishDate 2009-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Annals of Cardiac Anaesthesia
spelling doaj.art-145f0ab878354b13a48d19c1f10a1e4b2022-12-21T23:23:28ZengWolters Kluwer Medknow PublicationsAnnals of Cardiac Anaesthesia0971-97842009-01-01122122126Delay in onset of metabolic alkalosis during regional citrate anti-coagulation in continous renal replacement therapy with calcium-free replacement solutionSee KayLee MargaretMukhopadhyay AmartyaRegional citrate anti-coagulation for continuous renal replacement therapy chelates calcium to produce the anti-&#8197;coagulation effect. We hypothesise that a calcium-free replacement solution will require less citrate and produce fewer metabolic side effects. Fifty patients, in a Medical Intensive Care Unit of a tertiary teaching hospital (25 in each group), received continuous venovenous hemofiltration using either calcium-containing or calcium-free replacement solutions. Both groups had no significant differences in filter life, metabolic alkalosis, hypernatremia, hypocalcemia, and hypercalcemia. However, patients using calcium-containing solution developed metabolic alkalosis earlier, compared to patients using calcium-free solution (mean 24.6 hours,CI 0.8-48.4 vs. 37.2 hours, CI 9.4-65, <i> P </i> = 0.020). When calcium-containing replacement solution was used, more citrate was required (mean 280ml/h, CI 227.2-332.8 vs. 265ml/h, CI 203.4-326.6, <i> P </i> = 0.069), but less calcium was infused (mean 21.2 ml/h, CI 1.2-21.2 vs 51.6ml/h, CI 26.8-76.4, <i> P </i>&#8804; 0.0001).http://www.annals.in/article.asp?issn=0971-9784;year=2009;volume=12;issue=2;spage=122;epage=126;aulast=SeeRegional citrate anti-coagulationcontinuous renal replacement therapymetabolic alkalosisreplacement solutionfilter life
spellingShingle See Kay
Lee Margaret
Mukhopadhyay Amartya
Delay in onset of metabolic alkalosis during regional citrate anti-coagulation in continous renal replacement therapy with calcium-free replacement solution
Annals of Cardiac Anaesthesia
Regional citrate anti-coagulation
continuous renal replacement therapy
metabolic alkalosis
replacement solution
filter life
title Delay in onset of metabolic alkalosis during regional citrate anti-coagulation in continous renal replacement therapy with calcium-free replacement solution
title_full Delay in onset of metabolic alkalosis during regional citrate anti-coagulation in continous renal replacement therapy with calcium-free replacement solution
title_fullStr Delay in onset of metabolic alkalosis during regional citrate anti-coagulation in continous renal replacement therapy with calcium-free replacement solution
title_full_unstemmed Delay in onset of metabolic alkalosis during regional citrate anti-coagulation in continous renal replacement therapy with calcium-free replacement solution
title_short Delay in onset of metabolic alkalosis during regional citrate anti-coagulation in continous renal replacement therapy with calcium-free replacement solution
title_sort delay in onset of metabolic alkalosis during regional citrate anti coagulation in continous renal replacement therapy with calcium free replacement solution
topic Regional citrate anti-coagulation
continuous renal replacement therapy
metabolic alkalosis
replacement solution
filter life
url http://www.annals.in/article.asp?issn=0971-9784;year=2009;volume=12;issue=2;spage=122;epage=126;aulast=See
work_keys_str_mv AT seekay delayinonsetofmetabolicalkalosisduringregionalcitrateanticoagulationincontinousrenalreplacementtherapywithcalciumfreereplacementsolution
AT leemargaret delayinonsetofmetabolicalkalosisduringregionalcitrateanticoagulationincontinousrenalreplacementtherapywithcalciumfreereplacementsolution
AT mukhopadhyayamartya delayinonsetofmetabolicalkalosisduringregionalcitrateanticoagulationincontinousrenalreplacementtherapywithcalciumfreereplacementsolution